Old Web
English
Sign In
Acemap
>
authorDetail
>
Tiffany Kim
Tiffany Kim
Center for Drug Evaluation and Research
Medicine
AMOXICILLIN/CLAVULANATE
Physical therapy
Extensively drug-resistant tuberculosis
Diabetes mellitus
4
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Expanding spectrum of opportunistic infections associated with dimethyl fumarate.
2020
Multiple Sclerosis Journal
Tiffany Kim
David Croteau
Allen Brinker
David E Jones
Paul R Lee
Cindy Kortepeter
Show All
Source
Cite
Save
Citations (2)
Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease
2017
Open Forum Infectious Diseases
Ofer Zimmerman
B. Rosler
Christa S. Zerbe
Lindsey B. Rosen
Amy P. Hsu
Gulbu Uzel
Alexandra F. Freeman
Elizabeth P. Sampaio
S.D. Rosenzwieg
Hye Sun Kuehn
Tiffany Kim
K.M. Brooks
Parag Kumar
Xiaowen Wang
Mihai G. Netea
F.L. van de Veerdonk
S.M. Holland
Show All
Source
Cite
Save
Citations (30)
Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis
2017
European Respiratory Journal
Miriam E. Abadie
Jeffrey R. Strich
Tiffany Kim
Yingda L. Xie
Kevin P. Fennelly
Kenneth N. Olivier
Meryl Waldman
Kriti Arora
Steven M. Holland
Ray Y. Chen
Show All
Source
Cite
Save
Citations (1)
Safety and Tolerability of Long Term Use of Tedizolid for Treatment of Nontuberculous Mycobacterial Infections
2016
Open Forum Infectious Diseases
Tiffany Kim
Aprielle B. Wills
Alexandra Markus
D. Rebecca Prevots
Kenneth N. Olivier
Show All
Source
Cite
Save
Citations (12)
1